PTC Therapeutics | PTCT - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Daiichi Sankyo JPY 4.9T 1.44T 2026-04
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
Karyopharm Therapeutics USD 652M 517M 2026-04
Novartis USD 231.75B 76B 2026-04
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12